Anti-CD44 Antibody (Hermes-1)
Based on 2 publication(s) in Google Scholar
Anti-CD44 Antibody (Hermes-1) is a kind of rat IgG2a κ chimeric antibody, targeting to human CD44. Anti-CD44 Antibody (Hermes-1) blocks the binding of hyaluronan to CD44. Anti-CD44 Antibody (Hermes-1) restores (Platelet-derived Growth Factor-BB)-induced β-receptor activation and motility in fibroblasts. Anti-CD44 Antibody (Hermes-1) causes partial loss of the anti-aging effect of hyaluronic.
For research use only. We do not sell to patients.
- Purity : ≥95.0%
- Molecular Weight:150 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Anti-CD44 Antibody (Hermes-1)
More
Biological Activity
Description
Isotype
Rat IgG2a kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
CD44
In Vitro
Anti-CD44 Antibody (Hermes-1) (10 μg/mL, 12 h) increases SA-β-Gal-positive cells in human amniotic epithelial stem cells (hAECs)[1].
Anti-CD44 Antibody (Hermes-1) (25-50 μg/mL, 27 h) restores (Platelet-derived Growth Factor-BB)-induced β-receptor activation and motility in fibroblasts[2].
Anti-CD44 Antibody (Hermes-1) (50 μg/mL, 3 h) neutralizes the inhibitory effect of hyaluronan on PDGF-BB (Platelet-derived Growth Factor-BB)-induced β-receptor phosphorylation in fibroblasts[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Product Image
Application
in vivo CD44 blockade in xenografts; in vitro CD44 blockade; Western blot; Immunofluorescence
Chemical Information
-
Appearance Liquid
-
Molecular Weight 150 kDa
-
Color Colorless to light yellow
-
SMILES
[Anti-CD44 Antibody (Hermes-1)]
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
Magnetically triggered thermoelectric heterojunctions with an efficient magnetic-thermo-electric energy cascade conversion for synergistic cancer therapy. [Abstract]2025 Mar 10;16(1):2369. PMID: 40064895 -
Biomaterials
A biocompatible copper based therapeutic nanoplatform for CD44 specific tumor targeted therapy and potent immune reprogramming. [Abstract]2026 Jun 13:335:124373. PMID: 42314235
Purity & Documentation
-
Data Sheet (261 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Yu C, et al. Hyaluronan delays human amniotic epithelial stem cell senescence by regulating CD44 isoform switch to activate AKT/mTOR signals. Biomed Pharmacother. 2024 Jan;170:116100. [Content Brief]
[2]. Li L, et al. Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J Biol Chem. 2006 Sep 8;281(36):26512-9. [Content Brief]
[3]. Zhao C, et al. The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44. Oncotarget. 2019 Nov 12;10(61):6561-6576. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)